{"id":"https://openalex.org/W2012696366","doi":"https://doi.org/10.3109/08039488.2013.852243","title":"Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden","display_name":"Pharmacoeconomics of depot antipsychotics for treating chronic schizophrenia in Sweden","publication_year":2013,"publication_date":"2013-11-25","ids":{"openalex":"https://openalex.org/W2012696366","doi":"https://doi.org/10.3109/08039488.2013.852243","mag":"2012696366","pmid":"https://pubmed.ncbi.nlm.nih.gov/24274837"},"language":"en","primary_location":{"id":"doi:10.3109/08039488.2013.852243","doi":"https://doi.org/10.3109/08039488.2013.852243","is_oa":false,"landing_page_url":"https://doi.org/10.3109/08039488.2013.852243","pdf_url":null,"source":{"id":"https://openalex.org/S63111534","display_name":"Nordic Journal of Psychiatry","issn_l":"0029-1455","issn":["0029-1455","0803-9488","1502-4725"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nordic Journal of Psychiatry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017439960","display_name":"Thomas Ray Einarson","orcid":"https://orcid.org/0000-0003-3865-2533","observed_orcids":["https://orcid.org/0000-0003-3865-2533"]},"institutions":[{"id":"https://openalex.org/I185261750","display_name":"University of Toronto","ror":"https://ror.org/03dbr7087","country_code":"CA","type":"education","lineage":["https://openalex.org/I185261750"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Thomas R. Einarson","raw_affiliation_strings":["Thomas R. Einarson, Professor Emeritus, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Thomas R. Einarson, Professor Emeritus, Leslie Dan Faculty of Pharmacy, University of Toronto, Canada","institution_ids":["https://openalex.org/I185261750"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067553502","display_name":"Colin Vicente","orcid":"https://orcid.org/0000-0002-2940-1743","observed_orcids":["https://orcid.org/0000-0002-2940-1743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Colin Vicente","raw_affiliation_strings":["Colin Vicente, Pivina Consulting Inc., Mississauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Colin Vicente, Pivina Consulting Inc., Mississauga, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082728915","display_name":"Roman Zilbershtein","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Roman Zilbershtein","raw_affiliation_strings":["Roman Zilbershtein, Pivina Consulting Inc., Mississauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Roman Zilbershtein, Pivina Consulting Inc., Mississauga, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074969031","display_name":"Charles Piwko","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Charles Piwko","raw_affiliation_strings":["Charles Piwko, Pivina Consulting Inc., Mississauga, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles Piwko, Pivina Consulting Inc., Mississauga, Canada","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091774228","display_name":"Christel N. B\u00f8","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Christel N. B\u00f8","raw_affiliation_strings":["Christel N. B\u00f8, Janssen Cilag, Oslo, Norway"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Christel N. B\u00f8, Janssen Cilag, Oslo, Norway","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029518119","display_name":"Hanna Pudas","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanna Pudas","raw_affiliation_strings":["Hanna Pudas, Janssen Cilag, Espoo, Finland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hanna Pudas, Janssen Cilag, Espoo, Finland","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030379292","display_name":"R. Jensen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Rasmus Jensen","raw_affiliation_strings":["Rasmus Jensen, Janssen Cilag, Birker\u00f8d, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rasmus Jensen, Janssen Cilag, Birker\u00f8d, Denmark","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5109107941","display_name":"Michiel E. H. Hemels","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michiel E.H. Hemels","raw_affiliation_strings":["Michiel E. H. Hemels, Janssen Cilag, Birker\u00f8d, Denmark"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Michiel E. H. Hemels, Janssen Cilag, Birker\u00f8d, Denmark","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017439960"],"corresponding_institution_ids":["https://openalex.org/I185261750"],"apc_list":null,"apc_paid":null,"fwci":1.1905,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.77221799,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"68","issue":"6","first_page":"416","last_page":"427"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7817000150680542,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.7817000150680542,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.20890000462532043,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/long-acting-injectable-antipsychotics","display_name":"long-acting injectable antipsychotics","score":0.9200000166893005},{"id":"https://openalex.org/keywords/chronic-schizophrenia","display_name":"chronic schizophrenia","score":0.9879999756813049},{"id":"https://openalex.org/keywords/cost-effectiveness","display_name":"cost-effectiveness","score":0.9779999852180481},{"id":"https://openalex.org/keywords/paliperidone-palmitate","display_name":"paliperidone palmitate","score":0.9919999837875366},{"id":"https://openalex.org/keywords/olanzapine-pamoate","display_name":"olanzapine pamoate","score":0.9829999804496765},{"id":"https://openalex.org/keywords/risperidone","display_name":"risperidone","score":0.9520000219345093},{"id":"https://openalex.org/keywords/haloperidol-decanoate","display_name":"haloperidol decanoate","score":0.9990000128746033},{"id":"https://openalex.org/keywords/clozapine","display_name":"clozapine","score":0.8299999833106995},{"id":"https://openalex.org/keywords/quality-adjusted-life-years","display_name":"quality-adjusted life years","score":0.8389999866485596},{"id":"https://openalex.org/keywords/institutional-care-costs","display_name":"institutional care costs","score":0.7360000014305115},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.5260000228881836},{"id":"https://openalex.org/keywords/hospitalization","display_name":"hospitalization","score":0.6510000228881836},{"id":"https://openalex.org/keywords/sweden","display_name":"Sweden","score":0.734000027179718},{"id":"https://openalex.org/keywords/decision-tree","display_name":"decision tree","score":0.7160000205039978}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6884371042251587},{"id":"https://openalex.org/C2780057945","wikidata":"https://www.wikidata.org/wiki/Q412443","display_name":"Risperidone","level":3,"score":0.6466761827468872},{"id":"https://openalex.org/C2777126507","wikidata":"https://www.wikidata.org/wiki/Q423292","display_name":"Paliperidone","level":4,"score":0.6267430186271667},{"id":"https://openalex.org/C2776619155","wikidata":"https://www.wikidata.org/wiki/Q201872","display_name":"Olanzapine","level":3,"score":0.5500480532646179},{"id":"https://openalex.org/C3019080777","wikidata":"https://www.wikidata.org/wiki/Q1754768","display_name":"Cost effectiveness","level":2,"score":0.44845977425575256},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2337123155593872},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.1945434808731079},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068882","descriptor_name":"Paliperidone Palmitate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077152","descriptor_name":"Olanzapine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D003024","descriptor_name":"Clozapine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003362","descriptor_name":"Cost-Benefit Analysis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D006220","descriptor_name":"Haloperidol","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D007555","descriptor_name":"Isoxazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010168","descriptor_name":"Palmitates","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D010168","descriptor_name":"Palmitates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D013548","descriptor_name":"Sweden","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016527","descriptor_name":"Drug Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017059","descriptor_name":"Models, Econometric","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D018967","descriptor_name":"Risperidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019057","descriptor_name":"Quality-Adjusted Life Years","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.3109/08039488.2013.852243","doi":"https://doi.org/10.3109/08039488.2013.852243","is_oa":false,"landing_page_url":"https://doi.org/10.3109/08039488.2013.852243","pdf_url":null,"source":{"id":"https://openalex.org/S63111534","display_name":"Nordic Journal of Psychiatry","issn_l":"0029-1455","issn":["0029-1455","0803-9488","1502-4725"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nordic Journal of Psychiatry","raw_type":"journal-article"},{"id":"pmid:24274837","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24274837","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nordic journal of psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":78,"referenced_works":["https://openalex.org/W1552721554","https://openalex.org/W1790617688","https://openalex.org/W1842906670","https://openalex.org/W1962951813","https://openalex.org/W1963015295","https://openalex.org/W1965940175","https://openalex.org/W1969486406","https://openalex.org/W1973562905","https://openalex.org/W1974979812","https://openalex.org/W1980214914","https://openalex.org/W1982061015","https://openalex.org/W1985452390","https://openalex.org/W1986060217","https://openalex.org/W1986462877","https://openalex.org/W1989156396","https://openalex.org/W1989780779","https://openalex.org/W1989863594","https://openalex.org/W1990455568","https://openalex.org/W1994160244","https://openalex.org/W2000936213","https://openalex.org/W2002100947","https://openalex.org/W2004450883","https://openalex.org/W2009652756","https://openalex.org/W2009915038","https://openalex.org/W2013672598","https://openalex.org/W2014088019","https://openalex.org/W2014555657","https://openalex.org/W2014733711","https://openalex.org/W2016463457","https://openalex.org/W2018041786","https://openalex.org/W2022592863","https://openalex.org/W2030048493","https://openalex.org/W2037117217","https://openalex.org/W2040353650","https://openalex.org/W2040580072","https://openalex.org/W2041376702","https://openalex.org/W2043296995","https://openalex.org/W2045972565","https://openalex.org/W2046561367","https://openalex.org/W2046784620","https://openalex.org/W2052007245","https://openalex.org/W2055465804","https://openalex.org/W2056672347","https://openalex.org/W2058867975","https://openalex.org/W2061331619","https://openalex.org/W2064036552","https://openalex.org/W2065705954","https://openalex.org/W2067019476","https://openalex.org/W2068416846","https://openalex.org/W2072686355","https://openalex.org/W2074984017","https://openalex.org/W2076607047","https://openalex.org/W2083366597","https://openalex.org/W2085002778","https://openalex.org/W2085360366","https://openalex.org/W2089145934","https://openalex.org/W2098395209","https://openalex.org/W2098485231","https://openalex.org/W2099123602","https://openalex.org/W2099226437","https://openalex.org/W2107962758","https://openalex.org/W2108889485","https://openalex.org/W2115115146","https://openalex.org/W2123665981","https://openalex.org/W2135264258","https://openalex.org/W2138418531","https://openalex.org/W2140000974","https://openalex.org/W2141237725","https://openalex.org/W2143825289","https://openalex.org/W2145088514","https://openalex.org/W2147522149","https://openalex.org/W2151860626","https://openalex.org/W2157408003","https://openalex.org/W2159155203","https://openalex.org/W2162645527","https://openalex.org/W2164694650","https://openalex.org/W2168395707","https://openalex.org/W2333903607"],"related_works":["https://openalex.org/W2000275242","https://openalex.org/W4383900930","https://openalex.org/W2333903607","https://openalex.org/W2041778976","https://openalex.org/W4248312218","https://openalex.org/W2252889185","https://openalex.org/W2028802309","https://openalex.org/W2087722862","https://openalex.org/W2145088514","https://openalex.org/W2162645527"],"abstract_inverted_index":{"AIMS:":[0],"To":[1],"determine":[2],"the":[3,85,113,124,232,251],"cost-effectiveness":[4,97],"of":[5,167,202,231],"long-acting":[6],"injectable":[7],"(LAI)":[8],"antipsychotics":[9],"for":[10,22,171,244],"chronic":[11,245],"schizophrenia":[12,246],"in":[13,73,123,200,208,214,221,229,242],"Sweden.":[14],"METHODS:":[15],"A":[16],"1-year":[17],"decision":[18],"tree":[19],"was":[20,227,240],"developed":[21],"Sweden":[23,243],"using":[24],"published":[25],"data":[26],"and":[27,49,65,88,100,118,154,184,216,247],"expert":[28],"opinion.":[29],"Five":[30],"treatment":[31],"strategies":[32],"lasting":[33],"1":[34],"year":[35],"were":[36,71,93,170,176,180],"compared:":[37],"paliperidone":[38],"palmitate":[39],"(PP-LAI),":[40],"olanzapine":[41,50],"pamoate":[42],"(OLZ-LAI),":[43],"risperidone":[44],"(RIS-LAI),":[45],"haloperidol":[46],"decanoate":[47],"(HAL-LAI)":[48],"tablets":[51],"(oral-OLZ).":[52],"Patients":[53],"intolerant/failing":[54],"drugs":[55],"switched":[56],"to":[57,182,250],"another":[58],"depot;":[59],"subsequent":[60],"failures":[61],"received":[62],"clozapine.":[63],"Resources":[64],"employment":[66],"time":[67],"lost":[68],"(indirect":[69],"costs)":[70],"costed":[72],"2011":[74],"Swedish":[75],"kroner":[76],"(SEK),":[77],"from":[78],"standard":[79],"government":[80],"lists.":[81],"The":[82,164],"model":[83,105],"calculated":[84],"average":[86],"cost/patient":[87,115],"quality-adjusted":[89],"life-years":[90],"(QALYs),":[91],"which":[92],"combined":[94],"into":[95],"incremental":[96],"ratios.":[98],"Multivariate":[99],"1-way":[101],"sensitivity":[102],"analyses":[103],"tested":[104],"stability.":[106],"RESULTS:":[107],"PP-LAI":[108,130,191,199,223,236],"followed":[109,128,137,146,156,192,197,205,211,218,224,237],"by":[110,129,138,147,157,193,198,206,212,219,225,238],"OLZ-LAI":[111,127,194,196,226,239],"had":[112],"lowest":[114],"(189,696":[116],"SEK)":[117],"highest":[119],"QALYs":[120],"(0.817),":[121],"dominating":[122],"base":[125],"case.":[126],"cost":[131,140,149,159],"229,775":[132],"SEK":[133,142,151,161],"(0.812":[134],"QALY),":[135,144,153],"RIS-LAI":[136,204],"HAL-LAI":[139,145,158,207,210,220],"221,062":[141],"(0.804":[143],"oral-OLZ":[148,155,213,217],"243,411":[150],"(0.776":[152],"249,422":[160],"(0.773":[162],"QALY).":[163],"greatest":[165],"proportions":[166],"costs":[168,175],"(52.5-83.8%)":[169],"institutional":[172],"care;":[173],"indirect":[174],"minor":[177],"(2.4-3.8%).":[178],"RESULTS":[179],"sensitive":[181],"adherence":[183],"hospitalization":[185],"rates,":[186],"but":[187],"not":[188],"drug":[189],"cost.":[190],"dominated":[195,228],"59.4%":[201],"simulations,":[203],"65.8%,":[209],"94.0%":[215],"95.9%;":[222],"1.1%":[230],"40,000":[233],"iterations.":[234],"CONCLUSION:":[235],"cost-effective":[241],"cost-saving":[248],"overall":[249],"healthcare":[252],"system.":[253]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":6},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}